* Nemaura Medical Inc NMRD.OQ reported a quarterly
adjusted loss
of 17 cents per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 17 cents per share.
* Reported revenue was zero; analysts expected $450.00
thousand.
* Nemaura Medical Inc's reported EPS for the quarter was a
loss
of 17 cents.
* The mean earnings estimate of analysts had fallen by
about 21.4%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Nemaura Medical Inc shares had fallen by 7.8% this
quarter and
lost 48.0% so far this year.
* The company reported a quarterly loss of $3.98 million.
* Wall Street's median 12-month price target for Nemaura
Medical
Inc is $12.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 15
at 09:01 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.17 -0.17 Met
Mar. 31 2022 -0.14 -0.15 Missed
Dec. 31 2021 -0.14 -0.15 Missed
Sep. 30 2021 -0.11 -0.15 Missed